Arcturus Therapeutics
ARCT
#7365
Rank
C$0.51 B
Marketcap
$18.89
Share price
2.48%
Change (1 day)
-60.14%
Change (1 year)

Operating Margin for Arcturus Therapeutics (ARCT)

Operating Margin as of March 2025 (TTM): -52.91%

According to Arcturus Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -52.91%. At the end of 2024 the company had an Operating Margin of -58.49%.

Operating Margin history for Arcturus Therapeutics from 2018 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-58.49%230.83%
2023-17.68%-441.77%
20225.17%-100.31%
2021-1,647.98%117.89%
2020-756.35%504.97%
2019-125.02%-9.59%
2018-138.29%64.89%
2017-83.87%1012.87%
2016-7.54%-75.67%
2015-30.97%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
22.85%-143.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-234,760.00% 443,596.84% Bahamas

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.